Audia S, Brescia C, Dattilo V, Torchia N, Trapasso F, Amato R
Cancers (Basel). 2025; 17(1.
PMID: 39796684
PMC: 11718844.
DOI: 10.3390/cancers17010055.
Yasmeen F, Pirzada R, Ahmad B, Choi B, Choi S
Int J Mol Sci. 2024; 25(14).
PMID: 39062908
PMC: 11277571.
DOI: 10.3390/ijms25147666.
Specht C, Wang R, Oliveira L, Hester M, Gomez C, Mou Z
mBio. 2024; 15(8):e0174624.
PMID: 38980038
PMC: 11323574.
DOI: 10.1128/mbio.01746-24.
Cammayo-Fletcher P, Flores R, Nguyen B, Altanzul B, Fernandez-Colorado C, Kim W
Microorganisms. 2024; 12(5).
PMID: 38792803
PMC: 11123779.
DOI: 10.3390/microorganisms12050973.
Khan S, Bilal H, Khan M, Fang W, Chang W, Yin B
Front Immunol. 2024; 15:1372693.
PMID: 38605952
PMC: 11007146.
DOI: 10.3389/fimmu.2024.1372693.
Interleukins (IL-23 and IL-27) serum levels: Relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate.
Barac I, Vacaras V, Iancu M, Muresanu D, Procopciuc L
Heliyon. 2023; 9(6):e17427.
PMID: 37484355
PMC: 10361377.
DOI: 10.1016/j.heliyon.2023.e17427.
Characterisation of IL-23 receptor antagonists and disease relevant mutants using fluorescent probes.
Lay C, Isidro-Llobet A, Kilpatrick L, Craggs P, Hill S
Nat Commun. 2023; 14(1):2882.
PMID: 37208328
PMC: 10199020.
DOI: 10.1038/s41467-023-38541-2.
The regulatory mechanism and potential application of IL-23 in autoimmune diseases.
Xiong D, Shi X, Han M, Zhang X, Wu N, Sheng X
Front Pharmacol. 2022; 13:982238.
PMID: 36176425
PMC: 9514453.
DOI: 10.3389/fphar.2022.982238.
Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus.
Kotyla P, Gumkowska-Sroka O, Wnuk B, Kotyla K
Pharmaceuticals (Basel). 2022; 15(8).
PMID: 36015084
PMC: 9413112.
DOI: 10.3390/ph15080936.
Long Noncoding RNAs as Orchestrators of CD4 T-Cell Fate.
Liu C, Zhang Y, Ma Z, Yi H
Front Cell Dev Biol. 2022; 10:831215.
PMID: 35794862
PMC: 9251064.
DOI: 10.3389/fcell.2022.831215.
Suppression of IL-12/IL-23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon-γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon-driven diseases.
Vincken N, Welsing P, Silva-Cardoso S, Bekker C, Lopes A, Nordkamp M
Exp Dermatol. 2022; 31(6):962-969.
PMID: 35297512
PMC: 9313893.
DOI: 10.1111/exd.14566.
Targeted Immunotherapy for Autoimmune Disease.
Jung S, Kim W
Immune Netw. 2022; 22(1):e9.
PMID: 35291650
PMC: 8901705.
DOI: 10.4110/in.2022.22.e9.
JAK/STAT: Why choose a classical or an alternative pathway when you can have both?.
Puigdevall L, Michiels C, Stewardson C, Dumoutier L
J Cell Mol Med. 2022; 26(7):1865-1875.
PMID: 35238133
PMC: 8980962.
DOI: 10.1111/jcmm.17168.
T17 cells and corticosteroid insensitivity in severe asthma.
Xie Y, Abel P, Casale T, Tu Y
J Allergy Clin Immunol. 2021; 149(2):467-479.
PMID: 34953791
PMC: 8821175.
DOI: 10.1016/j.jaci.2021.12.769.
C-Reactive Protein Controls IL-23 Production by Human Monocytes.
Geyer C, Newling M, Sritharan L, Griffith G, Chen H, Baeten D
Int J Mol Sci. 2021; 22(21).
PMID: 34769069
PMC: 8583945.
DOI: 10.3390/ijms222111638.
Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease.
Roberts K, Cubitt M, Carlton T, Rodrigues-Duarte L, Maggiore L, Chai R
Sci Rep. 2021; 11(1):19422.
PMID: 34593832
PMC: 8484351.
DOI: 10.1038/s41598-021-97236-0.
Implications of a 'Third Signal' in NK Cells.
Khalil M, Wang D, Hashemi E, Terhune S, Malarkannan S
Cells. 2021; 10(8).
PMID: 34440725
PMC: 8393955.
DOI: 10.3390/cells10081955.
Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics.
Ben Abdallah H, Johansen C, Iversen L
Psoriasis (Auckl). 2021; 11:83-97.
PMID: 34235053
PMC: 8254604.
DOI: 10.2147/PTT.S294173.
An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses.
Hinckley J, Saba L, Raymond K, Bartels K, Klawitter J, Christians U
Cannabis Cannabinoid Res. 2021; 7(1):65-77.
PMID: 33998853
PMC: 8864439.
DOI: 10.1089/can.2020.0002.
Glutamine metabolism in Th17/Treg cell fate: applications in Th17 cell-associated diseases.
Yang G, Xia Y, Ren W
Sci China Life Sci. 2020; 64(2):221-233.
PMID: 32671630
DOI: 10.1007/s11427-020-1703-2.